Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...
The U.S. Food and Drug Administration (FDA) approved GSK's combination vaccine to protect against meningococcal infection for ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Hosted on MSN2h
FDA's approval of non-opioid pain pill could be game-changerThe Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an important alternative because the power of opioids helped fuel an ...
Some of the public health websites that the US government was ordered to restore involving gender and gender identity now ...
Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
President Donald Trump in January ordered federal workers back to the office full time, but some workers say they don't have a desk or an office to go back to.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results